XtalPi Holdings Ltd (02228.HK) Latest Company News

Oct 29, 2026, 07:39 UTC
XtalPi Holdings Ltd. and Singapore’s Agency for Science, Technology and Research signed a memorandum of understanding to collaborate on materials research and laboratory automation.
Source:
- finance.sina.cn
Oct 20, 2026, 00:54 UTC
XtalPi Holdings Ltd. Chairman and Executive Director Wen Shuhao used personal funds to purchase 3.793 million company shares on the open market, representing approximately 0.09% of issued shares, for a total consideration of approximately HK$25 million.
Source:
- aastocks.com
Oct 13, 2026, 00:36 UTC
Ailux appointed Lloyd S. Miller as its chief medical officer.
Source:
- finance.sina.cn
Oct 12, 2026, 00:34 UTC
XtalPi Holdings Ltd. open-sourced its lcms2yield quantitative AI model for chemical reaction yields, along with model weights, inference code, and training and evaluation datasets.
Source:
- finance.sina.cn
Oct 7, 2026, 14:37 UTC
XtalPi Holdings Ltd. chairman, executive director and co-founder Wen Shuhao bought 1.3 million ordinary shares in the company for approximately HK$9.5 million using his own funds through market transactions.
Source:
- finance.sina.cn
- aastocks.com
Oct 7, 2026, 08:12 UTC
XtalPi Holdings Ltd. shares fell 12.1% to HK$7.30.
Source:
- aastocks.com
Oct 6, 2026, 11:30 UTC
Inductive Bio launched Indy, an AI assistant for recurring medicinal chemistry tasks, and Beacon-2, a predictive model for designing compounds with lower estimated human doses.
Source:
- cen.acs.org
Oct 6, 2026, 01:02 UTC
XtalPi Holdings (02228.HK) repurchased 2.004 million shares on October 5 at prices between HK$7.78 and HK$7.88 per share, for about HK$15.6929 million.
Source:
- aastocks.com
Sep 30, 2026, 00:52 UTC
XtalPi announced the delivery and acceptance of a jointly developed graphite electrode intelligent raw material selection AI model with Fangda Carbon New Material Technology.
Source:
- finance.sina.cn
Sep 24, 2026, 00:43 UTC
XtalPi announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for its self-developed pan-TRK inhibitor KQTD-126, intended for the treatment of chronic intestinal pain associated with irritable bowel syndrome and inflammatory bowel disease.
Source:
- aastocks.com
Sep 21, 2026, 14:59 UTC
Hansoh AI Therapeutics (03378) signed a strategic cooperation framework agreement and an XtalPi Science technology platform licensing agreement with XtalPi to explore AI for Science applications in antibody design, innovative molecule design and drug R&D process optimization.
Source:
- aastocks.com
- aastocks.com
Sep 21, 2026, 02:24 UTC
XtalPi (2228.HK) announced a major product upgrade to its scientific agent platform XtalPi Science, launching over 80 proprietary scientific skills and tools and expanding its invitation-only testing program.
Source:
- finance.sina.cn
Sep 18, 2026, 08:12 UTC
Hong Kong stocks closed higher on September 18, 2026, with the Hang Seng Index up 146 points (0.6%) at 24,750 and the Hang Seng Tech Index up 94 points (2.2%) at 4,405, as Alibaba rose over 3% and Lenovo Group, Liuliumei, Lenovo Holdings, Yingsheng Holdings and GenScript Biotech hit record highs.
Source:
Sep 18, 2026, 01:52 UTC
LCC Technologies Ltd., a wholly-owned subsidiary of XtalPi Holdings, entered a drug discovery collaboration agreement with the Stanford University Board of Trustees to combine Stanford's disease biology research with LCC's AI-driven small-molecule drug discovery platform.
Source:
Aug 20, 2026, 01:46 UTC
On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.
Source:
- aastocks.com
- aastocks.com
Aug 12, 2026, 14:01 UTC
XtalPi launched its Genius Agent scientific AI agent at a promotional event in Shenzhen on August 11, 2026, and co-founded the Open Ecosystem Alliance for Scientific Intelligence with 26 partners.
Source:
- hkcd.com
Aug 6, 2026, 13:58 UTC
XtalPi (2228.HK) launched XtalPi Science, an AI for Science platform integrating large language models, scientific agents, and automated robotics laboratories, along with Genius Agents, a matrix of research agents.
Source:
- wap.eastmoney.com
Jul 30, 2026, 04:19 UTC
XtalPi (Shenzhen Jingtai Technology) jointly initiated the 'Scientific Intelligence Open Ecosystem Alliance' with 26 industry, university, and research partners on July 30, 2026.
Source:
- finance.sina.cn
Jul 30, 2026, 04:19 UTC
XtalPi (Shenzhen Jingtai Technology) launched the XtalPi Science scientific intelligence platform and Genius Agents scientific intelligence agent matrix on July 30, 2026.
Source:
- finance.sina.cn
- finance.sina.cn

02228.HK

XtalPi Holdings Ltd. and Singapore’s Agency for Science, Technology and Research signed a memorandum of understanding to collaborate on materials research and laboratory automation.

XtalPi Holdings Ltd. Chairman and Executive Director Wen Shuhao used personal funds to purchase 3.793 million company shares on the open market, representing approximately 0.09% of issued shares, for a total consideration of approximately HK$25 million.

Ailux appointed Lloyd S. Miller as its chief medical officer.

XtalPi Holdings Ltd. open-sourced its lcms2yield quantitative AI model for chemical reaction yields, along with model weights, inference code, and training and evaluation datasets.

XtalPi Holdings Ltd. chairman, executive director and co-founder Wen Shuhao bought 1.3 million ordinary shares in the company for approximately HK$9.5 million using his own funds through market transactions.

XtalPi Holdings Ltd. shares fell 12.1% to HK$7.30.

Inductive Bio launched Indy, an AI assistant for recurring medicinal chemistry tasks, and Beacon-2, a predictive model for designing compounds with lower estimated human doses.

XtalPi Holdings (02228.HK) repurchased 2.004 million shares on October 5 at prices between HK$7.78 and HK$7.88 per share, for about HK$15.6929 million.

XtalPi announced the delivery and acceptance of a jointly developed graphite electrode intelligent raw material selection AI model with Fangda Carbon New Material Technology.

Hansoh AI Therapeutics (03378) signed a strategic cooperation framework agreement and an XtalPi Science technology platform licensing agreement with XtalPi to explore AI for Science applications in antibody design, innovative molecule design and drug R&D process optimization.

XtalPi (2228.HK) announced a major product upgrade to its scientific agent platform XtalPi Science, launching over 80 proprietary scientific skills and tools and expanding its invitation-only testing program.

Hong Kong stocks closed higher on September 18, 2026, with the Hang Seng Index up 146 points (0.6%) at 24,750 and the Hang Seng Tech Index up 94 points (2.2%) at 4,405, as Alibaba rose over 3% and Lenovo Group, Liuliumei, Lenovo Holdings, Yingsheng Holdings and GenScript Biotech hit record highs.

LCC Technologies Ltd., a wholly-owned subsidiary of XtalPi Holdings, entered a drug discovery collaboration agreement with the Stanford University Board of Trustees to combine Stanford's disease biology research with LCC's AI-driven small-molecule drug discovery platform.

On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.

XtalPi launched its Genius Agent scientific AI agent at a promotional event in Shenzhen on August 11, 2026, and co-founded the Open Ecosystem Alliance for Scientific Intelligence with 26 partners.

XtalPi (2228.HK) launched XtalPi Science, an AI for Science platform integrating large language models, scientific agents, and automated robotics laboratories, along with Genius Agents, a matrix of research agents.

XtalPi (Shenzhen Jingtai Technology) jointly initiated the 'Scientific Intelligence Open Ecosystem Alliance' with 26 industry, university, and research partners on July 30, 2026.

XtalPi (Shenzhen Jingtai Technology) launched the XtalPi Science scientific intelligence platform and Genius Agents scientific intelligence agent matrix on July 30, 2026.